The global Pharmaceutical membrane filtration market is expected to develop US$ 10.1 billion by 2030, at a compound annual increase in price (CAGR) of 3.88% throughout the forecast period.
.jpg "The Global Pharmaceutical Membrane Filtration Market 2020-2030 (USD Billion)")
Membrane filtration procedures are broadly employed in various sectors such as pharmaceutical, biotechnology, and chemical production. Membrane filtration procedures are used as a valuable means of cleaning and filtering waste liquid, bacterial content and industrial procedure liquid. Membrane separation processes function without heating and therefore, use less energy than conventional thermal separation processes such as sublimation or crystallization, distillation. The separation process is purely physical and permeate & retentate can be used. In addition, spiral and tubular sheath plants to screen filths from drinking water have been recently installed in areas where the traditional management proved to be inefficient. Membrane filtration procedures provide confirmation about protection and effectiveness of the drug by eliminating impurities throughout the drug production process.
In pharmaceutical sector, membrane filtration technique is functional in several stages of drug production and development. Furthermore, use of membrane filtration technique involve large-scale drug manufacture, sample preparation, drug screening process, virus removal, laboratory water purification, protein separation, and lab-scale cell culturing. Rapid surge in adoption of pharmaceutical membrane filtration is credited to the stringent environmental protocols and Good Manufacturing Practices (GMP) in the pharmaceutical industry.
The increasing production of generics, rise in adoption of membrane filters in protein purification, sterile filtration, and viral clearance processes are boosting the growth of this market. Additionally, there has been a significant rise in the adoption of single-use technology as it provides cost-effective process that ensures the quality of biologics and maintains drug quality which has rapid growth in the pharmaceutical and biopharmaceutical industries. Moreover, the growing demand for nanofiltration are also the major factors driving the growth of this market. However, membrane fouling concerns, high capital investments for operations and strict regulatory policies are expected to hamper pharmaceutical membrane filtration market.
Systems segment is expected to witness significant growth in this market
Systems segment is anticipated to account for significant revenue share due to the rising adoption of single-use systems in pharmaceutical membrane filtration. The benefits associated with these systems include a high retention rate, reduced cross-contamination risk, low cost, and less consumption of energy.
North America anticipated to dominate the global market during the forecast period
North America is estimated to account for a significant market share owing to rapid adoption of the technology and well established healthcare sector. Growth of pharmaceutical membrane filtration market in North America can be attributed to several factors, such as the presence of key biopharmaceutical manufacturing facilities in the region and the significant spending on research and development activities in the US.
Key Market Players
- Merck KGaA
- ALFA LAVAL Corporate AB
- GEA Group Aktiengesellschaft
- Koch Membrane Systems, Inc.
- Pall Corporation
- Sartorius AG
- Danaher Corporation
- Others
pharmaceutical membrane filtration market Scope
| Metrics | Details |
| Base Year | 2023 |
| Historic Data | 2018-2022 |
| Forecast Period | 2024-2030 |
| Study Period | 2018-2030 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2030 | US$ 10.1 billion |
| Growth Rate | CAGR of 3.88% during 2020-2030 |
| Segment Covered | By Product, By Technique, By Application, By Systems, By Type, Regions |
| Regions Covered | By Labelling Technology, Printing Technology, Region. |
| Key Players Profiled | Graver Technologies, LLC, Meissner Filtration Products, Inc., Merck & Co., Inc., Parker-Hannifin Corporation, Sartorius Stedim Biotech S.A., 3M Company, Amazon Filters Ltd., Danaher Corporation (Pall Corporation), Eaton Corporation Plc, General Electric Company (GE Healthcare) |
Key Segment Of The pharmaceutical membrane filtration market
By Product (USD Billion)
o Membrane Filters
• MCE membrane filters
• Coated cellulose acetate membrane filters
• PTFE membrane filters
• Nylon membrane filters
• PVDF membrane filters
• Other membrane filters
o Pre-filters & Depth Media
• Glass fiber filters
• PTFE fiber filters
o Single-use Systems
o Cartridges & Capsules
o Filter Holders
o Filtration Accessories
o Filtration Assemblies
o Others
By Technique, (USD Billion)
• Microfiltration
• Ultrafiltration
• Crossflow filtration
• Nanofiltration
• Others
By Application, (USD Billion)
o Final Product Processing
• Active pharmaceutical ingredient filtration
• Sterile filtration
• Protein purification
• Vaccines and antibody processing
• Formulation and filling solutions
• Viral clearance
o Raw Material Filtration
• Media buffer
• Pre-filtration
• Bioburden testing
o Cell Separation
o Water Purification
o Air Purification
By Type, 2022-2030 (USD Billion)
• Sterile Filtration
• Non-Sterile Filtratio
By Scale of Operation, (USD Billion)
• Manufacturing scale
• Pilot-scale
• Research & development scale
By Systems, (USD Billion)
• Single Use
• Reusable
Regional Overview, (USD Billion)
North America
• US
• Canada
Europe
• Germany
• France
• UK
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Rest of Asia Pacific
South America
• Mexico
• Brazil
• Rest of South America
Middle East and South Africa
Frequently Asked Questions (FAQ) :
North America dominated the market for pharmaceutical membrane filtration market and accounted for the largest revenue share.
To get latest version of pharmaceutical membrane filtration market report can be obtained on demand from the website.
The base year for the report is 2023 in pharmaceutical membrane filtration market.